Key result
FARAPULSE linked to ~13-minute faster procedures than PulseSelect but more minor access site complications.
Why the study?
Does pulsed field ablation with a pentaspline catheter compared to a circular catheter improve procedural characteristics and safety in patients with atrial fibrillation?
Observational (n=402)
Yes
Does pulsed field ablation with a pentaspline catheter compared to a circular catheter improve procedural characteristics and safety in patients with atrial fibrillation?
Both pentaspline and circular pulsed field ablation systems offer excellent acute efficacy and safety for atrial fibrillation, though the pentaspline system is associated with shorter procedure times but higher rates of minor vascular access complications.
Answers are grounded in this paper and cite their sources.
Both PFA systems show strong acute performance in AF; extends real-world options but leaves randomized head-to-head data open.
BACKGROUND: There are few comparative studies on the everyday clinical outcomes of commercially available pulsed field ablation (PFA) systems for atrial fibrillation (AF). OBJECTIVE: This study evaluates the acute efficacy and safety outcomes of the FARAPULSE™ (pentaspline catheter) and PulseSelect™ (circular catheter) system. METHODS: International, multicenter, registry on patients with paroxysmal or persistent AF, undergoing a first ablation using either PFA system between January 29th, 2024 and September 1st, 2024. Primary endpoints were electrical isolation of ablation targets, procedural characteristics and freedom from major adverse events within 30 days postprocedure. RESULTS: A total of 402 patients were enrolled at the six participating centers, of whom 56.5% were treated with the pentaspline ablation-catheter. Acute procedural efficacy was 100% for both groups. Use of the pentaspline ablation-catheter was associated with significantly shorter procedural times (36.0 min [IQR 31.0; 44.0] vs. 49.0 min [IQR 41.5;76.0]) compared to the circular ablation-catheter (p < 0.001). Major adverse events were scarce and not different between cohorts. Two patients (0.5%) experienced a stroke and one patient (0.2%) had a serious vascular access site complication. One patient had a transient ischemic attack (0.2%). Minor vascular access site complications were more common in the pentaspline catheter group (11.9% vs. 1.1%, p < 0.001). CONCLUSIONS: This study showed excellent acute efficacy and safety for both PFA-systems. Our findings reveal shorter procedural times with the pentaspline catheter, less minor access site complications with the circular catheter, and several procedural differences between the ablation systems, often driven by operator choice.
No takes yet. Share an insight, caveat, or question.
Abeln et al. (2025) conducted an observational in Paroxysmal or persistent atrial fibrillation (n=402). FARAPULSE (pentaspline catheter) vs. PulseSelect (circular catheter) was evaluated on Electrical isolation of ablation targets, procedural characteristics and freedom from major adverse events within 30 days postprocedure.
Synapse has enriched 10 related papers. Consider them for comparative context: